CHRONIC HEPATITIS B
Clinical trials for CHRONIC HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test antibody shot in bid to cure hepatitis b
⭐️ CURE ⭐️ TerminatedThis small pilot study tested whether injections of Hepatitis B antibodies could help the body clear the virus in people with a long-term infection. The goal was to see if this treatment could lead to a functional cure, meaning the virus is undetectable without needing ongoing me…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Hannover Medical School • Aim: ⭐️ CURE ⭐️
Last updated Mar 30, 2026 14:32 UTC
-
First human tests for hepatitis b drug halted
Disease control TerminatedThis early study tested a new drug called RO7565020 to see if it's safe for people with chronic hepatitis B. Researchers gave the drug to 60 healthy volunteers and hepatitis B patients to check for side effects and how the body processes it. The study was terminated after this in…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Halted trial tests new shot at taming hepatitis b
Disease control TerminatedThis study tested whether adding a new intravenous drug called ARC-520 to standard oral medications (entecavir or tenofovir) could more effectively reduce the amount of Hepatitis B virus in the body. It involved a small group of adults with a specific type of chronic Hepatitis B …
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC